Psychopharmacology and Psychiatry Updates Managing Lithium's Renal Risks: Evidence-Based Strategies
9 snips
Mar 27, 2026 
David Osser, Associate Professor of Psychiatry at Harvard Medical School and psychopharmacology expert, breaks down lithium's renal risks with clear evidence. He discusses actual risk numbers and who is higher risk. He covers monitoring frequency, dosing strategies to prevent toxicity, key drug interactions, and practical approaches for managing polyuria and edema.
AI Snips
Chapters
Transcript
Episode notes
Severe Kidney Harm From Lithium Is Uncommon
- Severe renal toxicity from lithium is rarer than feared with a number needed to harm around 300.
- That NNH may be much higher when clinicians avoid high levels, use once-daily immediate-release night dosing, and follow best practices described by David Osser.
Check Kidney Function Every 4–6 Months
- Monitor kidney function at least every six months, with some guidance favoring checks every four months for higher vigilance.
- Check serum creatinine and eGFR regularly so emerging declines are detected early, especially in higher-risk patients.
Refer Nephrology When Creatinine Hits 1.6 Or eGFR <60
- Consult nephrology if creatinine ≥1.6 mg/dL or eGFR drops below 60 and weigh risks versus benefits before stopping lithium.
- Evaluate for reversible causes and adjust dosing first, since impairment can be temporary or multifactorial.